{
  "ticker": "ANO",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02967824",
  "id": "02967824",
  "pages": 1,
  "price_sensitive": false,
  "date": "20250709",
  "time": "1520",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250709/pdf/06ln0r5wh7340l.pdf",
  "summary": "- **Key Material Information:**  \n  - **New Tariff Threat:** 200% tariff on Australian pharmaceutical companies if they don\u2019t relocate to the USA within 18 months (exemption for Australian zinc oxide).  \n  - **Competitive Landscape:** Major competitors in Japan/South Korea face 25% tariffs from 1 August 2025; ANO\u2019s products remain tariff-free.  \n  - **Relocation Feasibility:** ANO could relocate US-sourced equipment to the USA if required, citing past success in production moves.  \n  - **No Immediate Impact:** ANO expects no negative effect on its U.S. business at this stage.  \n\nOmitted: Speculative government negotiation outcomes, non-operative details.",
  "usage": {
    "prompt_tokens": 495,
    "completion_tokens": 151,
    "total_tokens": 646,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-09T05:37:46.154608"
}